Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Thalidomide
Trade Name: thalomid
Date Designated: 10/14/1998
Orphan Designation: Treatment of multiple myeloma
Orphan Designation Status: Designated/Approved
Celgene Corporation
P.O. Box 4914
7 Powder Horn Srive
Warren, New Jersey 07059
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Thalidomide
Trade Name: thalomid
Marketing Approval Date: 05/25/2006
Approved Labeled Indication: Treatment of patients with newly diagnosed multiple myeloma
Exclusivity End Date: 05/25/2013 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-